Clinical Trial Update: Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of autologous cultured keratinocyte cells for severe burn wounds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Wound

Drugs mentioned

• Autologous Cultured Keratinocyte Cells (keratinocyte cell therapy)

Snippet

Sponsor: Biosolution Co., Ltd. | Conditions: Burn Wound | Phase 3 | Status: UNKNOWN